Latest Insider Transactions at Arcus Biosciences, Inc. (RCUS)
This section provides a real-time view of insider transactions for Arcus Biosciences, Inc. (RCUS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Arcus Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Arcus Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,241
-1.79%
|
$84,820
$20.72 P/Share
|
|
Jun 16
2022
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
1,400
-5.22%
|
$28,000
$20.72 P/Share
|
|
Jun 14
2022
|
Kathryn E Falberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+4.33%
|
-
|
|
Jun 14
2022
|
Yasunori Kaneko Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+50.0%
|
-
|
|
Jun 14
2022
|
David L. Lacey Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+8.81%
|
-
|
|
Jun 14
2022
|
Nicole Lambert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+50.0%
|
-
|
|
Jun 14
2022
|
Patrick Machado Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+28.87%
|
-
|
|
Jun 14
2022
|
Andrew J Perlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+26.93%
|
-
|
|
Jun 14
2022
|
Antoni Ribas Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,100
+21.3%
|
-
|
|
Mar 16
2022
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,617
-8.32%
|
$298,127
$31.62 P/Share
|
|
Mar 08
2022
|
Juan C. Jaen President |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+11.85%
|
-
|
|
Mar 08
2022
|
Jennifer Jarrett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+20.41%
|
-
|
|
Mar 08
2022
|
Ii Robert C. Goeltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+40.77%
|
-
|
|
Mar 08
2022
|
Carolyn C. Tang General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+32.46%
|
-
|
|
Mar 08
2022
|
Terry J Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+19.03%
|
-
|
|
Mar 07
2022
|
Terry J Rosen Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
321,074
-100.0%
|
-
|
|
Feb 28
2022
|
Juan C. Jaen President |
SELL
Bona fide gift
|
Indirect |
350,000
-22.26%
|
-
|
|
Dec 20
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
34,822
-10.05%
|
$1,427,702
$41.6 P/Share
|
|
Dec 17
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,943
-0.34%
|
$117,720
$40.11 P/Share
|
|
Dec 17
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,118
-1.37%
|
$284,720
$40.11 P/Share
|
|
Dec 17
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
1,108
-0.14%
|
$44,320
$40.11 P/Share
|
|
Dec 17
2021
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
621
-2.09%
|
$24,840
$40.11 P/Share
|
|
Dec 17
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
622
-0.87%
|
$24,880
$40.11 P/Share
|
|
Dec 16
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,299
-0.53%
|
$91,960
$40.03 P/Share
|
|
Dec 16
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,560
-2.03%
|
$222,400
$40.03 P/Share
|
|
Dec 16
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
865
-0.21%
|
$34,600
$40.03 P/Share
|
|
Dec 16
2021
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
485
-3.02%
|
$19,400
$40.03 P/Share
|
|
Dec 16
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
487
-1.31%
|
$19,480
$40.03 P/Share
|
|
Sep 21
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,866
-6.69%
|
$590,310
$35.74 P/Share
|
|
Sep 20
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,634
-6.64%
|
$1,072,190
$35.4 P/Share
|
|
Aug 03
2021
|
Nicole Lambert Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,700
+50.0%
|
-
|
|
Jun 17
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,891
-15.81%
|
$89,493
$23.68 P/Share
|
|
Jun 17
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
2,675
-1.33%
|
$61,525
$23.68 P/Share
|
|
Jun 17
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,863
-3.47%
|
$111,849
$23.68 P/Share
|
|
Jun 17
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,863
-2.31%
|
$111,849
$23.68 P/Share
|
|
Jun 17
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
1,606
-9.46%
|
$36,938
$23.68 P/Share
|
|
Jun 16
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,174
-5.74%
|
$76,176
$24.45 P/Share
|
|
Jun 16
2021
|
Juan C. Jaen President |
SELL
Open market or private sale
|
Direct |
2,182
-0.54%
|
$52,368
$24.45 P/Share
|
|
Jun 16
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,968
-1.38%
|
$95,232
$24.45 P/Share
|
|
Jun 16
2021
|
Terry J Rosen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,968
-0.93%
|
$95,232
$24.45 P/Share
|
|
Jun 16
2021
|
Carolyn C. Tang General Counsel |
SELL
Open market or private sale
|
Direct |
1,309
-3.59%
|
$31,416
$24.45 P/Share
|
|
Jun 04
2021
|
Jennifer Jarrett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,044
-0.87%
|
$25,056
$24.91 P/Share
|
|
Jun 03
2021
|
Kathryn E Falberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+3.35%
|
-
|
|
Jun 03
2021
|
Yasunori Kaneko Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+33.33%
|
-
|
|
Jun 03
2021
|
David L. Lacey Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+7.25%
|
-
|
|
Jun 03
2021
|
Patrick Machado Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+33.33%
|
-
|
|
Jun 03
2021
|
Andrew J Perlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+35.19%
|
-
|
|
Jun 03
2021
|
Antoni Ribas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+21.35%
|
-
|
|
Apr 23
2021
|
William Grossman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,133
-38.09%
|
$128,123
$31.37 P/Share
|
|
Apr 23
2021
|
Yasunori Kaneko Director |
BUY
Open market or private purchase
|
Direct |
4,133
+36.69%
|
$128,123
$31.37 P/Share
|